Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis-Reference-Cited by-同舟云学术

Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis

Published:2012-09-10 Issue:11b Volume:110 Page:E661-E666
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Di Lorenzo Giuseppe,Buonerba Carlo,Federico Piera,Perdonà Sisto,Aieta Michele,Rescigno Pasquale,D'Aniello Carmine,Puglia Livio,Petremolo Antonella,Ferro Matteo,Marinelli Alfredo,Palmieri Giovannella,Sonpavde Guru,Mirone Vincenzo,De Placido Sabino

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11453.x/fullpdf

Reference22 articles.

1. EAU penile cancer guidelines 2009;Pizzocaro;Eur Urol,2010

2. Prognostic factors in penile cancer;Ficarra;Urology,2010

3. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy;Bezerra;Cancer,2001

4. Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer;Pettaway;Urology,2010

5. cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study;Gagliano;J Urol,1989

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study;The Oncologist;2024-09-02

2. Overview of Systemic Therapies in Penile Cancer;Urologic Clinics of North America;2024-08

3. New Therapeutic Horizons for Advanced or Metastatic Penile Cancer;Urologic Clinics of North America;2024-08

4. Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study;Clinical Genitourinary Cancer;2024-06

5. Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies;Expert Opinion on Pharmacotherapy;2024-03-03